What does RESEARCH WITH RESPECT TO PREMENSTRUAL DYSPHORIC DISORDER of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This section directs the Secretary of Health and Human Services, through the National Institutes of Health, to expand and intensify research on Premenstrual Dysphoric Disorder (PMDD). The research should focus on the causes, risk factors, diagnosis, and treatment of PMDD. Clinical trials are to be supported to develop improved treatment options for PMDD. Research must ensure adequate representation of diverse racial, ethnic, and socioeconomic populations. The Secretary is required to collect and publish data on the prevalence and incidence of PMDD across populations. Data collection also includes the economic and workforce impact of PMDD, as well as barriers to diagnosis and treatment. Appropriations are authorized for fiscal years 2027 through 2031 to carry out these activities.

What does EDUCATION AND DISSEMINATION OF INFORMATION WITH RESPECT TO of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This section mandates a public health awareness campaign regarding Premenstrual Dysphoric Disorder (PMDD). The campaign aims to raise awareness of PMDD symptoms and treatment options among patients and healthcare providers. The section also seeks to reduce stigma associated with menstrual health conditions and encourage timely medical care. The Health Resources and Services Administration will develop and disseminate continuing medical education materials for healthcare providers. These materials will focus on accurate PMDD diagnosis, differentiation from other conditions, and evidence-based care. The Secretary is required to coordinate the campaign with existing Department of Health and Human Services programs. Appropriations are authorized for fiscal years 2026 through 2030 to support the implementation of this section.

What does GRANTS TO TRAIN HEALTH PROFESSIONALS WITH RESPECT TO PMDD. of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This section establishes a grant program to train health professionals regarding Premenstrual Dysphoric Disorder (PMDD). Eligible entities, including accredited schools and hospitals, can apply for grants to develop, establish, or expand training programs. These training programs should focus on improving care, treatment, and management services for PMDD. The Secretary will expand outreach activities to support training programs and address barriers to access to primary and specialty care for mid-life women's health. The training programs should also address early detection, diagnosis, treatment, and care services for perimenopause, menopausal symptoms, and related chronic conditions. The program is authorized for appropriations from fiscal years 2027 through 2031.

What does REPORT ON IMPACTS ON PMDD RESEARCH AND TREATMENT. of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This section requires the Secretary to submit a report to Congress within two years of the Act's enactment. The report must detail progress in expanding research on Premenstrual Dysphoric Disorder (PMDD). The report must also address improvements in awareness and education regarding PMDD. Furthermore, the report should cover increasing access to diagnosis and treatment for PMDD. The section authorizes appropriations for fiscal years 2027 through 2031 to carry out these activities.

Back to bills

Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

Q: What does Preamble of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This bill aims to expand research related to Premenstrual Dysphoric Disorder (PMDD). The bill also seeks to improve awareness of PMDD. It intends to increase access to treatment for individuals affected by PMDD.

Q: What does SHORT TITLE. of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This bill is formally titled the Premenstrual Dysphoric Disorder Awareness and Research Act of 2026.

Q: What does FINDINGS. of Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 do?

This section establishes findings related to Premenstrual Dysphoric Disorder (PMDD). PMDD is described as a severe, chronic, and often disabling medical condition affecting an estimated 5 to 8 percent of women and people assigned female at birth of reproductive age. The condition is characterized by mood shifts, irritability, depression, and physical symptoms that impair daily life. The findings state that PMDD is under-diagnosed, under-researched, and stigmatized. Early detection, treatment, and awareness are considered essential for improving the quality of life for those living with PMDD.

Last updated: 3/30/2026 · Introduced: 3/30/2026

Author: Yassamin Ansari (D-AZ)

TL;DR (AI)

This bill directs the National Institutes of Health to expand research on Premenstrual Dysphoric Disorder (PMDD), focusing on causes, risk factors, and improved treatment options, while ensuring diverse representation in research.
The bill mandates a public health awareness campaign to educate patients and healthcare providers about PMDD symptoms, treatment, and to reduce stigma associated with the condition.
It establishes a grant program to train health professionals on PMDD diagnosis, treatment, and management, including related women's health conditions, and requires a report to Congress detailing progress in research and treatment.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 5 more.

7 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account